Endogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions
Mast cell stabilizers like cromoglycate and nedocromil are mainstream treatments for ocular allergy. Biochemical studies in vitro suggest that these drugs prevent mast cell degranulation through the release of Annexin-A1 (Anx-A1) protein. However, the direct effect of Anx-A1 gene deletion on mast ce...
Main Authors: | Ajantha Sinniah, Samia Yazid, Stefania Bena, Sonia M. Oliani, Mauro Perretti, Rod J. Flower |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01313/full |
Similar Items
-
Mast Cells and Their Progenitors in Allergic Asthma
by: Erika Méndez-Enríquez, et al.
Published: (2019-05-01) -
Effects of artemisinin on early-phase response of allergic conjunctivitis in a murine model induced by pollen
by: Jing-Jing Zhu, et al.
Published: (2016-06-01) -
Coptisine Suppresses Mast Cell Degranulation and Ovalbumin-Induced Allergic Rhinitis
by: Shuilian Fu, et al.
Published: (2018-11-01) -
Evaluating the effectiveness of a sodium cromoglycate group drug in the treatment of allergic conjunctivitis
by: S. Sh. Mirrakhimova, et al.
Published: (2020-05-01) -
Elaeocarpusin Inhibits Mast Cell-Mediated Allergic Inflammation
by: Min-Jong Kim, et al.
Published: (2018-06-01)